Keita Ino

Title: Keita Ino: Innovator in Stem Cell Research

Introduction

Keita Ino is a prominent inventor based in Hyogo, Japan. He has made significant contributions to the field of stem cell research, holding a total of 3 patents. His work focuses on developing safe and effective cell populations for pharmaceutical applications.

Latest Patents

One of his latest patents is titled "Cell population including adhesive stem cells, production method therefor and pharmaceutical composition." This invention aims to provide a cell population comprising safe adherent stem cells that maintain a normal karyotype. The production method involves obtaining a cell population where the proportion of KCNAB1-positive adherent stem cells is 85% or more.

Another notable patent is "Cell population comprising adherent cells derived from fetal appendage, method for producing the same, and pharmaceutical composition." This invention provides a cell population with adherent cells having low differentiation capacity derived from a fetal appendage. The methods for producing or using this cell population ensure that the proportion of CD73- and CD90-positive adherent cells is 90% or more, among other specific criteria.

Career Highlights

Keita Ino is currently employed at Kaneka Corporation, where he continues to advance his research in stem cell technology. His innovative work has positioned him as a key figure in the field, contributing to the development of new therapeutic options.

Collaborations

He collaborates with notable coworkers, including Yuta Kita and Nobuyoshi Umeda, who share his passion for advancing stem cell research.

Conclusion

Keita Ino's contributions to stem cell research through his patents and work at Kaneka Corporation highlight his role as an influential inventor in the field. His innovative approaches promise to enhance the understanding and application of stem cell technology in medicine.